| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |